Targeted Genetics (Nasdaq: TGEN) is seeing renewed momentum today following Tuesday's news of a restructured debt deal with Biogen Idec ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE